Good morning, everyone, and nice to see you again. As usual, another busy is under way as we scurry about the Pharmalot corporate campus trying to hustle the short people to their schoolhouses and urge the mascots to finish fertilizing the weeds as quickly as possible. Meanwhile, we would like to remind you that we are hosting a webinar next week on healthcare payer and players and you can join us (
please see this). And now, time to get busy. Here are some tidbits to get you started. Hope you survive today and accomplish much...Merck Serono Confirms Geneva HQ To Close (Pharma Times)
Pfizer Paid $896M To Resolve Prempro Claims (Bloomberg News)
Massachusetts Lawmakers Debate Bill For Presription Drug Coupons (WWLP)
Merck And Geisinger Health Form Collaboration (Philadelphia Inquirer)
FDA Rejects Pfizer Drug For Rare Neurodegenerative Disorder (The Day)
FDA Staff Question Value Of Sanofi Blood Clot Drug (Reuters)
Glaxo And Novartis Get US Grants To Make Vaccines (Reuters)
Walgreens To Buy 45 Percent Stake In Boots (Reuters)
US Kids Are Prescribed More ADHD Pills Than Antibiotics (Agence France Presse)
Canadian Online Pharmacy Pioneer Is Arrested In Florida (CBC)
EDITOR'S NOTE: Please check this post for updates during the day
steaming coffee pic thx to dleggett on flickr
1 Comment
In fact the EU is the most anticompetitive venture in history and another reason why EU countries are in such sorry shape. Doubly ironic in that the EU was originaslly formed to bring about competition with the US.
Britain to the EU: LMAO.